These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9756086)

  • 21. The development of potent and specific vasopressin antagonists.
    Sawyer WH; Manning M
    Kidney Int Suppl; 1988 Oct; 26():S34-7. PubMed ID: 3059031
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of action of vasopressin and vasopressin antagonists.
    Jard S
    Kidney Int Suppl; 1988 Oct; 26():S38-42. PubMed ID: 2974096
    [No Abstract]   [Full Text] [Related]  

  • 23. Are aquaporin water channels the "holy grail" of primary nocturnal enuresis?
    Davis ID; MacRae Dell K
    J Urol; 2002 Mar; 167(3):1451-2. PubMed ID: 11832769
    [No Abstract]   [Full Text] [Related]  

  • 24. Genes, familial enuresis, and clinical management.
    Super M; Postlethwaite RJ
    Lancet; 1997 Jul; 350(9072):159-60. PubMed ID: 9250180
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of vasopressin antagonists in human diseases.
    Thibonnier M
    Kidney Int Suppl; 1988 Oct; 26():S48-51. PubMed ID: 2974097
    [No Abstract]   [Full Text] [Related]  

  • 26. [The clinical and experimental pharmacology of vasopressin agonists and antagonists].
    Rudichenko VM
    Eksp Klin Farmakol; 1994; 57(2):68-73. PubMed ID: 8205056
    [No Abstract]   [Full Text] [Related]  

  • 27. Seasonal rhythms of vasopressin release and aquaporin-2 excretion assure appropriate water conservation in humans.
    Goswami N; Di Mise A; Centrone M; Russo A; Ranieri M; Reichmuth J; Brix B; De Santo NG; Sasso FC; Tamma G; Valenti G
    J Transl Med; 2021 May; 19(1):194. PubMed ID: 33952296
    [No Abstract]   [Full Text] [Related]  

  • 28. Thematic Review Series VI: Skin Gene Therapy Introduction.
    Katz SI
    Proc Assoc Am Physicians; 1999 May; 111(3):183. PubMed ID: 10354356
    [No Abstract]   [Full Text] [Related]  

  • 29. Thematic review series VII: genetic variability in response to infection introduction.
    Weatherall D
    Proc Assoc Am Physicians; 1999 Jul; 111(4):271. PubMed ID: 10417732
    [No Abstract]   [Full Text] [Related]  

  • 30. Somatosin receptors: An introduction.
    Meyerhof W
    J Physiol Paris; 2000 May; 94(3-4):165-6. PubMed ID: 11087992
    [No Abstract]   [Full Text] [Related]  

  • 31. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK; Nielsen S; Kurtz I
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thematic review series II: vasopressin: genes, receptors, water channels, and antagonists. Introduction.
    Schrier RW
    Proc Assoc Am Physicians; 1998; 110(5):379. PubMed ID: 9756086
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
    Schrier RW; Fassett RG; Ohara M; Martin PY
    Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aquaporin-2 water channels and vasopressin antagonists in edematous disorders.
    Schrier RW; Ohara M; Rogachev B; Xu L; Knotek M
    Mol Genet Metab; 1998 Dec; 65(4):255-63. PubMed ID: 9889012
    [No Abstract]   [Full Text] [Related]  

  • 36. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
    van Os CH; Deen PM
    Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.